Myron Holubiak
2019
In 2019, Myron Holubiak earned a total compensation of $764.1K as Chief Executive Officer at Citius Pharmaceuticals, a 12% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $204,750 |
---|---|
Option Awards | $109,380 |
Salary | $450,000 |
Total | $764,130 |
Holubiak received $450K in salary, accounting for 59% of the total pay in 2019.
Holubiak also received $204.8K in non-equity incentive plan and $109.4K in option awards.
Rankings
In 2019, Myron Holubiak's compensation ranked 10,400th out of 13,971 executives tracked by ExecPay. In other words, Holubiak earned more than 25.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,400 | 26th |
Manufacturing | 4,211 | 26th |
Chemicals And Allied Products | 1,626 | 26th |
Drugs | 1,394 | 26th |
Pharmaceutical Preparations | 1,033 | 26th |
Holubiak's colleagues
We found two more compensation records of executives who worked with Myron Holubiak at Citius Pharmaceuticals in 2019.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018